SwipeRx Funding: $37M Raised, Series B (2023)

SwipeRx funding overview

SwipeRx is based in Jakarta, Indonesia. SwipeRx has raised $37M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for SwipeRx runs through 2023; nothing later has been disclosed. Investors on record include Sanofi, Johnson & Johnson, Bill and Melinda Gates Foundation, MDI Ventures, Susquehanna International Group (SIG). 5 distinct backers are named across the disclosed rounds.

SwipeRx at a glance

Total raised: $37M
Latest round: Series B
Latest round date: January 2023
Headquarters: Jakarta, Indonesia
Notable investors: Sanofi, Johnson & Johnson, Bill and Melinda Gates Foundation, MDI Ventures, Susquehanna International Group (SIG)

Frequently asked about SwipeRx funding

How much has SwipeRx raised?: SwipeRx has raised $37M in total disclosed funding across the rounds on record.
Who has invested in SwipeRx?: Sanofi, Johnson & Johnson, Bill and Melinda Gates Foundation, MDI Ventures, Susquehanna International Group (SIG) are named among the investors backing SwipeRx.
What was the latest SwipeRx funding round?: The most recent disclosed round is a Series B, announced in January 2023.
Where is SwipeRx based?: SwipeRx is based in Jakarta, Indonesia.
When did SwipeRx last raise?: The last disclosed SwipeRx round closed in January 2023 at Series B.

SwipeRx totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Jakarta below to benchmark round size and investor mix.

SwipeRx Funding: $37M Raised, Series B (2023)

SwipeRx funding overview

SwipeRx at a glance

Frequently asked about SwipeRx funding

Companies related to SwipeRx (36)

Browse related funding lists (6)